OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 97 filers reported holding OLEMA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,721,364 | +39.8% | 301,325 | +2.2% | 0.00% | 0.0% |
| Q2 2023 | $2,661,647 | +950.9% | 294,756 | +303.8% | 0.00% | – |
| Q1 2023 | $253,283 | +52.9% | 72,992 | +7.9% | 0.00% | – |
| Q4 2022 | $165,664 | -11.4% | 67,618 | -0.2% | 0.00% | – |
| Q3 2022 | $187,000 | -23.7% | 67,735 | +12.5% | 0.00% | – |
| Q2 2022 | $245,000 | -75.1% | 60,200 | -73.9% | 0.00% | – |
| Q1 2022 | $983,000 | -58.2% | 230,883 | -8.1% | 0.00% | – |
| Q4 2021 | $2,350,000 | -65.4% | 251,108 | +2.0% | 0.00% | -100.0% |
| Q3 2021 | $6,788,000 | +81.8% | 246,265 | +84.5% | 0.00% | 0.0% |
| Q2 2021 | $3,734,000 | -13.5% | 133,442 | +2.6% | 0.00% | 0.0% |
| Q1 2021 | $4,317,000 | +546.3% | 130,108 | +835.9% | 0.00% | – |
| Q4 2020 | $668,000 | – | 13,902 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 7,803,600 | $96,374,460 | 6.54% |
| Logos Global Management LP | 3,743,875 | $46,236,856 | 6.17% |
| MPM BioImpact LLC | 1,857,681 | $22,942,360 | 6.12% |
| Cormorant Asset Management, LP | 4,504,764 | $55,633,835 | 3.24% |
| BVF INC/IL | 9,135,893 | $112,828,279 | 3.04% |
| Vivo Capital, LLC | 1,873,704 | $23,140,244 | 2.54% |
| Altium Capital Management LP | 335,000 | $4,137,250 | 2.16% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 407,801 | $5,036,342 | 1.53% |
| HighVista Strategies LLC | 247,880 | $3,061,318 | 1.42% |
| ACUTA CAPITAL PARTNERS, LLC | 153,007 | $1,889,636 | 1.27% |